Artificial Intelligence Systems for Diabetic Retinopathy Screening: Appraisal on the 3rd US FDA Approved Algorithms- AEYE-DS
Journal Title: Journal of Ophthalmology and Advance Research - Year 2023, Vol 4, Issue 2
Abstract
Artificial Intelligence (AI) has revolutionized the field of healthcare in recent years, and one of its most promising applications is on the interpretation of medical images [1]. In ophthalmology, the first success comes to the screening and diagnosis of Diabetic Retinopathy (DR) [2]. DR is a common complication of Diabetes Mellitus (DM) that affects the eyes, and early detection and treatment is crucial in preventing vision loss, especially over the working populations [3]. The use of AI in DR screening involves analyzing digital fundus images to detect any signs of DR, including microaneurysms, dot and blot haemorrhages, cotton-wool spots, venous beading, intraretinal microvascular anomalies [4]. Currently, there are 3 US FDA approved systems on DR screening, IDx-DR (Digital Diagnostics), EyeArt (Eyenuk, Inc) and AEYE-DS (AEYE Health, Inc) [5-7]. AI has several advantages over traditional screening methods, including usage by non-ophthalmologically trained medical personnel, accessible and stable performance over whatever time and place, increased speed of clinical workflow, these might potentially help to improve outcomes for patients with DM. In the era of rapidly advancing technology, the use of AI in ophthalmology is an exciting development that might transform our future practice [8]. In this appraisal, we focus on the 3rd US FDA approved AI algorithms for DR.
Authors and Affiliations
Vanessa, Ching Chi Lee, Sunny Chi Lik Au
Keywords
Related Articles
- EP ID EP718833
- DOI https://doi.org/10.46889/JOAR.2023.4202
- Views 45
- Downloads 0
Awareness About Refractive Error Among Students in Primary Schools
Introduction: The uncorrected Refractive Errors (REs) cause visual impairment in more than 300 million subjects worldwide. Correction of uncorrected REs is a priority of Vision 2020-The Right to Sight. The study aimed to...
The Ophthalmology Development of Hyperbaric Medicine for Treating Central Retinal Artery Occlusion in Hong Kong
Hong Kong first established the Hyperbaric Oxygen Therapy (HBOT) for treatment of Central Retinal Artery Occlusion (CRAO) since November 2018 [1]. Before the era of hospital-based HBOT in 2018, similar service was prov...
Ocular Causes of Headache in Patients Presenting To a Sub-Urban Eye Hospital
Background: Headache is one of the most frequent complaints for which the patients visit the medical practitioners. The current study was planned to determine the aetiology of headache in patients seen for an ocular ex...
Peculiarities of Ocular and Systemic Pathology in the Elderly
The pathology of the elderly is the direct result of the aging process, aggravated by the physical and mental involution that occurs with advancing age. Age-related eye changes are present, such as: presbyopia, decreased...
Conjunctival Folliculosis Presenting as Hemolacria
A 13-year-old female reported a one-year history of hemolacria in her left eye following an episode of a migraine attack and anger outburst. Ophthalmic examination revealed inferior fornix follicles with petechia and abs...